Medline Inc. shares advanced Monday as Wall Street analysts struck a bullish tone on the medical supplier’s business model and growth prospects following its $7.2 billion IPO last month.
Sign in to read the full article.
Sign in with Google
Medline Inc. shares advanced Monday as Wall Street analysts struck a bullish tone on the medical supplier’s business model and growth prospects following its $7.2 billion IPO last month.
Sign in to read the full article.
Sign in with Google